Transcatheter aortic valve implantation with either CoreValve or SAPIEN XT devices in patients with a single coronary artery

Emmanuel Sorbets; Michael Choby; Didier Tchetche

Transcatheter aortic valve implantation with either CoreValve or SAPIEN XT devices in patients with a single coronary artery

J Invasive Cardiol. 2012 Jul;24(7):342-4.

Authors

Emmanuel Sorbets¹, Michael Choby, Didier Tchetche

Affiliation

¹ Clinique Pasteur, Groupe CardioVasculaire Interventionnel, 45 avenue de Lombez, 31300, Toulouse, France.

PMID: 22781474

Abstract

Transcatheter aortic valve implantation (TAVI) is associated with a risk of coronary obstruction. This complication is potentially lethal when the origin of the coronary arteries is anomalous. We describe two cases of TAVI with the SAPIEN XT (Edwards Lifesciences) and CoreValve devices (Medtronic) in patients with a single coronary artery. The tools and techniques used to anticipate the risk of acute coronary occlusion are discussed.

Publication types

Case Reports

MeSH terms

Aged, 80 and over
Aortic Valve / surgery*
Aortic Valve Stenosis / surgery*
Cardiac Catheters*
Coronary Angiography
Coronary Occlusion / epidemiology*
Coronary Vessel Anomalies / complications*
Coronary Vessel Anomalies / diagnostic imaging
Female
Heart Valve Prosthesis / adverse effects
Heart Valve Prosthesis / classification*
Humans
Prosthesis Implantation / adverse effects
Prosthesis Implantation / instrumentation
Prosthesis Implantation / methods*
Risk Factors
Sinus of Valsalva / abnormalities
Treatment Outcome